Previous 10 | Next 10 |
ACCESSWIRE news releases related Accesswire news releases and Accesswire press releases from 04/02/19 08:00:00 on US and Canada Markets.
Reports on Commercial Progress for both PainShield® and UroShield® ELMSFORD, NY / ACCESSWIRE / April 2, 2019 / NanoVibronix, Inc ., (NASDAQ: NAOV) , a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, ...
Animal Study Demonstrates Combination of HS-110 and HS-130 Yields Three-Fold Increase in Anti-Tumor CD8+ T-cell Expansion DURHAM, NC / ACCESSWIRE / April 2, 2019 / Heat Biologics, Inc. (NASDAQ: HTBX), a biopharmaceutical company developing immunotherapies designed to activate a patien...
SAN DIEGO, CA / ACCESSWIRE / April 2, 2019 / Dthera™ Sciences (OTCQB: DTHR) a leading digital therapeutic company specializing in neurodegenerative diseases, today announced that its Board of Directors has initiated a process to pursue a range of potential strategic transactions to en...
VANCOUVER, BC / ACCESSWIRE / April 2, 2019 / First Mining Gold Corp. ("First Mining" or the "Company") (TSX: FF) (OTCQX: FFMGF) (FRANKFURT: FMG) is pleased to announce the appointment of Mal Karwowska as the Company's Vice President, Corporate Development and Investor Relations, effective Ap...
LIVINGSTON, NJ / ACCESSWIRE / April 2, 2019 / Milestone Scientific Inc . (NYSE American: MLSS ), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the three months...
- Clinical data highlight potential utility of T cell clonality as a predictive and prognostic biomarker of pelareorep therapy - - Using pelareorep in advance of the checkpoint inhibitor Keytruda® safely primes the immune system to target cancer cells in pancreatic cancer patients ...
Results of Phase Ib Non-Muscle Invasive Bladder Cancer ("NMIBC") Clinical Study Demonstrate a 66% Complete Response ("CR") at the Therapeutic Dose (0.70 mg/cm2) 360 Days Post Treatment TORONTO, ON / ACCESSWIRE / April 2, 2019 / Theralase Technologies Inc. (" Theralase® " or the " C...
SAN FRANSISCO, CA / ACCESSWIRE / April 2, 2019 / Napo Pharmaceuticals, Inc. (Napo), a human health company developing and commercializing novel gastrointestinal prescription products from plants used traditionally in rainforest areas, and a wholly-owned subsidiary of Jaguar Health, Inc. (NAS...
VANCOUVER, BC and SAN CARLOS, CA / ACCESSWIRE / April 2, 2019 / (OTCQB: FOGCF; CSE: FOG; FRA: MUU3) FogChain Corp. ("FogChain" or the "Company") is excited to announce a major new release update with Trident's rapid application development suite, RadJav. Trident is a unified cross-platfo...
DUBLIN / ACCESSWIRE / April 2, 2019 / CRH plc, the global building materials group, is pleased to announce that it has completed the fourth phase of its share buyback programme, returning a further €200 million of cash to shareholders. Between 2 January and 29 March 2019, 7.6 million...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
-1.16%Change Percent:
MaxLinear Inc Company Name:
MXL Stock Symbol:
NYSE Market:
maxlinear.com Website: